ログイン

9. OTHER ISBT I

9. OTHER ISBT I
100問 • 2年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    ISBT 005:

    LUTHERAN

  • 2

    ISBT ?: LUTHERAN

    005

  • 3

    ISBT 005: Lutheran Prevalence:

    Lu (a-b+) > Lu (a+b+)> Lu (a+b-), > Lu(a-b-)

  • 4

    = IgM,IgA, IgG

    Anti Lub

  • 5

    Anti Lub =

    IgM,IgA, IgG

  • 6

    seen only after PREGNANT or transfusion.

    Anti Lub

  • 7

    post transfusion JAUNDICE

    Anti Lub

  • 8

    well developed at birth

    ISBT 006: Kell

  • 9

    K Antigen is __________ to D Antigen in immunogenicity.

    SECOND

  • 10

    is SECOND to D Antigen in immunogenicity.

    K Antigen

  • 11

    (kell)

    K

  • 12

    K (?)

    kell

  • 13

    k (?)

    cellano

  • 14

    (cellano)

    k

  • 15

    K - cellano Js?

    Jsb

  • 16

    K - kell Js?

    Jsa

  • 17

    Anti K – IgG__________ is seen with Anti K titer as low as 64

    STILL BIRTH

  • 18

    – IgG STILL BIRTH is seen with Anti K titer as low as 64

    Anti K

  • 19

    Anti K – IgG STILL BIRTH is seen with Anti K titer as low as ?

    64

  • 20

    McLeod Phenotype __________ Kell system

    DECREASE

  • 21

    DECREASE Kell system

    McLeod Phenotype

  • 22

    hemolytic anemia, poikilocytosis, neurologic , and muscular abnormalities (Duchene).

    McLeod Phenotype

  • 23

    McLeod Phenotype DISEASES

    hemolytic anemia, poikilocytosis, neurologic , and muscular abnormalities (Duchene).

  • 24

    Granulomatous disease (CGD) IS A

    McLeod Phenotype

  • 25

    ISBT 007:

    Lewis

  • 26

    ISBT ?: Lewis

    007

  • 27

    not synthesized by RBC, but from plasma ADSORBED by RBC membrane.

    ISBT 007: Lewis

  • 28

    enzyme resistant

    ISBT 007: Lewis

  • 29

    ISBT 007: Lewis Frequency a.Newborn

    Le (a-,b-)

  • 30

    ISBT 007: Lewis Frequency Shortly after birth

    Le>Se, phenotype: Le (a+, b-)

  • 31

    ISBT 007: Lewis Frequency After 10 days

    Le=Se, phenotype: Le (a+, b+)

  • 32

    ISBT 007: Lewis Frequency >6 years

    Le<Se, phenotype: Le (a-, b+)

  • 33

    ISBT 007: Lewis Frequency Le<Se, phenotype: Le (a-, b+)

    >6 years

  • 34

    ISBT 007: Lewis Frequency Le=Se, phenotype: Le (a+, b+)

    After 10 days

  • 35

    ISBT 007: Lewis Frequency Le>Se, phenotype: Le (a+, b-)

    Shortly after birth

  • 36

    ISBT 007: Lewis Frequency Le (a-,b-)

    Newborn

  • 37

    TYPE I CHAIN

    RBC

  • 38

    TYPE II CHAIN

    SECRETION

  • 39

    SECRETION

    TYPE II CHAIN

  • 40

    RBC

    TYPE I CHAIN

  • 41

    Leb – receptor for __________

    H. PYLORI

  • 42

    – receptor for H. PYLORI

    Leb

  • 43

    – increased SUSCEPTIBILITY to Candida and uropathogenic E.col

    Le (a-b-)

  • 44

    Le (a-b-) – increased SUSCEPTIBILITY to ? and ?

    Candida, uropathogenic E.col

  • 45

    _________ marker for reed sternberg cell

    Lex

  • 46

    Lex marker for

    reed sternberg cell

  • 47

    Anti Lewis can be neutralized using:

    PLASMA, SERUM, SALIVA

  • 48

    RARELY Cause HTR but not HDFN

    Lewis

  • 49

    cytokine receptors: proinflammatory (DARC – Duffy Antigen Receptor for Chemokines)

    ISBT 008: Duffy

  • 50

    ISBT 008:

    Duffy

  • 51

    ISBT ?: Duffy

    008

  • 52

    cytokine receptors: ? (DARC – Duffy Antigen Receptor for Chemokines)

    proinflammatory

  • 53

    cytokine receptors: proinflammatory (DARC – ?)

    Duffy Antigen Receptor for Chemokines

  • 54

    .Fy (a-b-)- resistant to __________

    P. VIVAX

  • 55

    .Fy (a-b-)- resistant to P. VIVAX; IN VITRO:

    P. KNOWLESI

  • 56

    ?- resistant to P. VIVAX

    Fy (a-b-)

  • 57

    P. VIVAX AND P. KNOWLESI ASSO. TO WHAT ISBT?

    ISBT 008: Duffy

  • 58

    Antibodies - Anti Fya and Fyb –assoc.to delayed _________

    HEMOLYTIC TRANSFUSION REACTION

  • 59

    Antibodies - ?–assoc.to delayed HEMOLYTIC TRANSFUSION REACTION

    Anti Fya and Fyb

  • 60

    ISBT 009: Kidd DISCOVERED TO

    MRS. KIDD

  • 61

    ISBT 009: Kidd Antibodies – (?)

    IgG

  • 62

    have NOTORIOUS reputation in blood bank.

    Antibodies – (IgG)

  • 63

    Not very immunogenic

    ISBT 009: Kidd

  • 64

    not denatured by enzyme

    ISBT 009: Kidd

  • 65

    Jk (a-b-) – resist __________

    2 MOLAR UREA

  • 66

    – resist 2 MOLAR UREA

    Jk (a-b-)

  • 67

    Jkb like Org:

    P.mirabilis, E.enterococcus, and Micrococcus

  • 68

    both high prevalence

    ISBT 027 Ii

  • 69

    ISBT ? Ii

    027

  • 70

    ISBT 027 ?

    Ii

  • 71

    Newborn ; RICH I CORD BLOOD

    ISBT 027 Ii

  • 72

    ISBT 027 Ii Newborn REPRESENTS AS

    i

  • 73

    ISBT 027 Ii i REPRESENTS AS

    Newborn

  • 74

    ISBT 027 Ii Adult REPRESENTS AS

    I / trace i

  • 75

    ISBT 027 Ii Adult “i"

    Rare phenotype, did not change

  • 76

    did not demonstrate classical I or i specificity, They concluded that the agglutinin recognizes a TRANSITION state of i into I

    I^T

  • 77

    I^T did not demonstrate classical I or i specificity, They concluded that the agglutinin recognizes a __________ state of i into I

    TRANSITION

  • 78

    ISBT 010:

    Diego

  • 79

    ISBT ?: Diego

    010

  • 80

    ISBT 010: Diego part of band 3 which is __________Exchange for HCO3 and C

    ANION

  • 81

    part of band 3 which is ANION Exchange for HCO3 and C

    ISBT 010: Diego

  • 82

    ISBT 010: Diego marker for __________

    MONGOLIAN ANCESTRY

  • 83

    ? marker for MONGOLIAN ANCESTRY

    ISBT 010: Diego

  • 84

    ISBT 011: -

    The YT (Cartwright)

  • 85

    ISBT ?: The YT (Cartwright) -

    011

  • 86

    ISBT 011: The YT (Cartwright) -Link to __________

    RBC ACETYLCHOLINESTERASE

  • 87

    -Link to RBC ACETYLCHOLINESTERASE

    ISBT 011: The YT (Cartwright)

  • 88

    ISBT 012: Xg -higher in __________

    FEMALE

  • 89

    -higher in FEMALE

    ISBT 012: Xg

  • 90

    ISBT 012:

    Xg

  • 91

    ISBT ?: Xg

    012

  • 92

    ISBT 013: Scianna -Gene product is –

    ERMAP (Erythroid membrane Assoc.Protein)

  • 93

    -Gene product is ERMAP (Erythroid membrane Assoc.Protein) –

    ISBT 013: Scianna

  • 94

    ISBT 013:

    Scianna

  • 95

    ISBT ?: Scianna

    013

  • 96

    -carried on a MONO-ADPribosyltransferase 4 (ART4)

    ISBT 014: Dombrock

  • 97

    ISBT 014:

    Dombrock

  • 98

    ISBT : Dombrock

    014

  • 99

    ISBT 014: Dombrock -carried on a

    MONO-ADPribosyltransferase 4 (ART4)

  • 100

    ISBT 015: Colton -carried

    aquaporin 1 (AQP1)

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    ISBT 005:

    LUTHERAN

  • 2

    ISBT ?: LUTHERAN

    005

  • 3

    ISBT 005: Lutheran Prevalence:

    Lu (a-b+) > Lu (a+b+)> Lu (a+b-), > Lu(a-b-)

  • 4

    = IgM,IgA, IgG

    Anti Lub

  • 5

    Anti Lub =

    IgM,IgA, IgG

  • 6

    seen only after PREGNANT or transfusion.

    Anti Lub

  • 7

    post transfusion JAUNDICE

    Anti Lub

  • 8

    well developed at birth

    ISBT 006: Kell

  • 9

    K Antigen is __________ to D Antigen in immunogenicity.

    SECOND

  • 10

    is SECOND to D Antigen in immunogenicity.

    K Antigen

  • 11

    (kell)

    K

  • 12

    K (?)

    kell

  • 13

    k (?)

    cellano

  • 14

    (cellano)

    k

  • 15

    K - cellano Js?

    Jsb

  • 16

    K - kell Js?

    Jsa

  • 17

    Anti K – IgG__________ is seen with Anti K titer as low as 64

    STILL BIRTH

  • 18

    – IgG STILL BIRTH is seen with Anti K titer as low as 64

    Anti K

  • 19

    Anti K – IgG STILL BIRTH is seen with Anti K titer as low as ?

    64

  • 20

    McLeod Phenotype __________ Kell system

    DECREASE

  • 21

    DECREASE Kell system

    McLeod Phenotype

  • 22

    hemolytic anemia, poikilocytosis, neurologic , and muscular abnormalities (Duchene).

    McLeod Phenotype

  • 23

    McLeod Phenotype DISEASES

    hemolytic anemia, poikilocytosis, neurologic , and muscular abnormalities (Duchene).

  • 24

    Granulomatous disease (CGD) IS A

    McLeod Phenotype

  • 25

    ISBT 007:

    Lewis

  • 26

    ISBT ?: Lewis

    007

  • 27

    not synthesized by RBC, but from plasma ADSORBED by RBC membrane.

    ISBT 007: Lewis

  • 28

    enzyme resistant

    ISBT 007: Lewis

  • 29

    ISBT 007: Lewis Frequency a.Newborn

    Le (a-,b-)

  • 30

    ISBT 007: Lewis Frequency Shortly after birth

    Le>Se, phenotype: Le (a+, b-)

  • 31

    ISBT 007: Lewis Frequency After 10 days

    Le=Se, phenotype: Le (a+, b+)

  • 32

    ISBT 007: Lewis Frequency >6 years

    Le<Se, phenotype: Le (a-, b+)

  • 33

    ISBT 007: Lewis Frequency Le<Se, phenotype: Le (a-, b+)

    >6 years

  • 34

    ISBT 007: Lewis Frequency Le=Se, phenotype: Le (a+, b+)

    After 10 days

  • 35

    ISBT 007: Lewis Frequency Le>Se, phenotype: Le (a+, b-)

    Shortly after birth

  • 36

    ISBT 007: Lewis Frequency Le (a-,b-)

    Newborn

  • 37

    TYPE I CHAIN

    RBC

  • 38

    TYPE II CHAIN

    SECRETION

  • 39

    SECRETION

    TYPE II CHAIN

  • 40

    RBC

    TYPE I CHAIN

  • 41

    Leb – receptor for __________

    H. PYLORI

  • 42

    – receptor for H. PYLORI

    Leb

  • 43

    – increased SUSCEPTIBILITY to Candida and uropathogenic E.col

    Le (a-b-)

  • 44

    Le (a-b-) – increased SUSCEPTIBILITY to ? and ?

    Candida, uropathogenic E.col

  • 45

    _________ marker for reed sternberg cell

    Lex

  • 46

    Lex marker for

    reed sternberg cell

  • 47

    Anti Lewis can be neutralized using:

    PLASMA, SERUM, SALIVA

  • 48

    RARELY Cause HTR but not HDFN

    Lewis

  • 49

    cytokine receptors: proinflammatory (DARC – Duffy Antigen Receptor for Chemokines)

    ISBT 008: Duffy

  • 50

    ISBT 008:

    Duffy

  • 51

    ISBT ?: Duffy

    008

  • 52

    cytokine receptors: ? (DARC – Duffy Antigen Receptor for Chemokines)

    proinflammatory

  • 53

    cytokine receptors: proinflammatory (DARC – ?)

    Duffy Antigen Receptor for Chemokines

  • 54

    .Fy (a-b-)- resistant to __________

    P. VIVAX

  • 55

    .Fy (a-b-)- resistant to P. VIVAX; IN VITRO:

    P. KNOWLESI

  • 56

    ?- resistant to P. VIVAX

    Fy (a-b-)

  • 57

    P. VIVAX AND P. KNOWLESI ASSO. TO WHAT ISBT?

    ISBT 008: Duffy

  • 58

    Antibodies - Anti Fya and Fyb –assoc.to delayed _________

    HEMOLYTIC TRANSFUSION REACTION

  • 59

    Antibodies - ?–assoc.to delayed HEMOLYTIC TRANSFUSION REACTION

    Anti Fya and Fyb

  • 60

    ISBT 009: Kidd DISCOVERED TO

    MRS. KIDD

  • 61

    ISBT 009: Kidd Antibodies – (?)

    IgG

  • 62

    have NOTORIOUS reputation in blood bank.

    Antibodies – (IgG)

  • 63

    Not very immunogenic

    ISBT 009: Kidd

  • 64

    not denatured by enzyme

    ISBT 009: Kidd

  • 65

    Jk (a-b-) – resist __________

    2 MOLAR UREA

  • 66

    – resist 2 MOLAR UREA

    Jk (a-b-)

  • 67

    Jkb like Org:

    P.mirabilis, E.enterococcus, and Micrococcus

  • 68

    both high prevalence

    ISBT 027 Ii

  • 69

    ISBT ? Ii

    027

  • 70

    ISBT 027 ?

    Ii

  • 71

    Newborn ; RICH I CORD BLOOD

    ISBT 027 Ii

  • 72

    ISBT 027 Ii Newborn REPRESENTS AS

    i

  • 73

    ISBT 027 Ii i REPRESENTS AS

    Newborn

  • 74

    ISBT 027 Ii Adult REPRESENTS AS

    I / trace i

  • 75

    ISBT 027 Ii Adult “i"

    Rare phenotype, did not change

  • 76

    did not demonstrate classical I or i specificity, They concluded that the agglutinin recognizes a TRANSITION state of i into I

    I^T

  • 77

    I^T did not demonstrate classical I or i specificity, They concluded that the agglutinin recognizes a __________ state of i into I

    TRANSITION

  • 78

    ISBT 010:

    Diego

  • 79

    ISBT ?: Diego

    010

  • 80

    ISBT 010: Diego part of band 3 which is __________Exchange for HCO3 and C

    ANION

  • 81

    part of band 3 which is ANION Exchange for HCO3 and C

    ISBT 010: Diego

  • 82

    ISBT 010: Diego marker for __________

    MONGOLIAN ANCESTRY

  • 83

    ? marker for MONGOLIAN ANCESTRY

    ISBT 010: Diego

  • 84

    ISBT 011: -

    The YT (Cartwright)

  • 85

    ISBT ?: The YT (Cartwright) -

    011

  • 86

    ISBT 011: The YT (Cartwright) -Link to __________

    RBC ACETYLCHOLINESTERASE

  • 87

    -Link to RBC ACETYLCHOLINESTERASE

    ISBT 011: The YT (Cartwright)

  • 88

    ISBT 012: Xg -higher in __________

    FEMALE

  • 89

    -higher in FEMALE

    ISBT 012: Xg

  • 90

    ISBT 012:

    Xg

  • 91

    ISBT ?: Xg

    012

  • 92

    ISBT 013: Scianna -Gene product is –

    ERMAP (Erythroid membrane Assoc.Protein)

  • 93

    -Gene product is ERMAP (Erythroid membrane Assoc.Protein) –

    ISBT 013: Scianna

  • 94

    ISBT 013:

    Scianna

  • 95

    ISBT ?: Scianna

    013

  • 96

    -carried on a MONO-ADPribosyltransferase 4 (ART4)

    ISBT 014: Dombrock

  • 97

    ISBT 014:

    Dombrock

  • 98

    ISBT : Dombrock

    014

  • 99

    ISBT 014: Dombrock -carried on a

    MONO-ADPribosyltransferase 4 (ART4)

  • 100

    ISBT 015: Colton -carried

    aquaporin 1 (AQP1)